Tunable IOLs, FDA news lead December cataract surgery coverage
December’s top cataract surgery stories include a blog entry speculating about the impact of tunable IOLs on exchanges and an FDA approvable letter for the IC-8 IOL.
Read December’s best-performing cataract surgery stories below.
BLOG: Tunable IOLs will end exchanges
Through their careers, most cataract surgeons become extremely comfortable with and adept at performing phacoemulsification, removing even the most challenging lenses and placing lens implants with little stress. Read more.
AcuFocus receives approvable letter from FDA for IC-8 IOL
AcuFocus has received an approvable letter from the FDA regarding the IC-8 small aperture IOL, according to a press release from the company. Read more.
Tecnis Synergy shows good performance at all distances in refractive lens exchange
Read more.
Novel intraocular ring enhances IOL stability, prevents PCO
A novel intraocular ring provides good centration and stable holding of IOLs in the capsular bag, while effectively preventing posterior capsule opacification. Read more.
Using intracanalicular dexamethasone insert after cataract surgery saves office time
NEW ORLEANS — Using Dextenza as a postoperative steroid treatment after cataract surgery saved practices about 40 staff hours per week on patient education and callbacks, according to a survey. Read more.